2005
DOI: 10.1016/j.ijgo.2005.01.009
|View full text |Cite
|
Sign up to set email alerts
|

A critical assessment of screening methods for cervical neoplasia

Abstract: The objective of cervical cancer screening is to reduce cervical cancer incidence and mortality by detecting and treating precancerous lesions. Conventional cytology is the most widely used cervical cancer screening test. Although cytology has been effective in reducing the incidence of and mortality from cervical cancer in developed countries in both opportunistic and--more dramatically--organized national programs, it has been less successful and largely ineffective in reducing disease burden in low-resource… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

8
191
2
10

Year Published

2006
2006
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 248 publications
(211 citation statements)
references
References 30 publications
8
191
2
10
Order By: Relevance
“…The sensitivity of VIA testing in detecting highgrade CIN and cervical cancer ranged from 67-79% and the specificity varied from 49-86% in previous crosssectional studies which used VIA testing as a primary screening test (Denny et al, 2002;Cronje et al, 2003;Sankaranarayanan et al, 2004;Sankaranarayanan et al, 2005). Our study demonstrated overall sensitivity and specificity of 59.4% and 76.2%, respectively of VIA testing in detecting high-grade CIN in women with minor cervical cytological abnormalities.…”
Section: Discussionmentioning
confidence: 46%
“…The sensitivity of VIA testing in detecting highgrade CIN and cervical cancer ranged from 67-79% and the specificity varied from 49-86% in previous crosssectional studies which used VIA testing as a primary screening test (Denny et al, 2002;Cronje et al, 2003;Sankaranarayanan et al, 2004;Sankaranarayanan et al, 2005). Our study demonstrated overall sensitivity and specificity of 59.4% and 76.2%, respectively of VIA testing in detecting high-grade CIN in women with minor cervical cytological abnormalities.…”
Section: Discussionmentioning
confidence: 46%
“…46,47 In a study of nearly 80,000 women in India aged 30-59 screened with VIA, there was a 25% reduction in cervical cancer incidence and 35% reduction in cancer deaths, as compared to a control group that was not screened. Benefits were most marked for women in their 30s.…”
Section: Making Screening and Pre-cancer Treatment Accessiblementioning
confidence: 99%
“…24 Several issues have been cited to explain the low coverage rates, including lack of awareness among the target population; inadequate trained personnel to perform the screening tests, read smears and interpret the results; poor communication between the screening sites and laboratories; and inaccessibility of the facilities to diagnose and treat patients who have been detected through the screening process. 25,26 In addition, population-based surveys, conducted in settings similar to those in South Africa, have reported gross inequalities in screening coverage. 27 The women who are at highest risk of developing cervical cancer are among the least likely to be screened.…”
Section: Discussionmentioning
confidence: 99%